Transcription Factor FoxO1 Mediates Glucagon-Like Peptide-1 Effects on Pancreatic β-Cell Mass
The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Abstract
The glucoincretin hormone glucagon-like peptide-1 (GLP-1) increases pancreatic β-cell proliferation and survival through sequential activation of the epidermal growth factor receptor (EGFR), phosphatidylinositol-3 kinase (PI 3-kinase), and Akt. We investigated the role of transcription factor FoxO1 in the proliferative and antiapoptotic actions of GLP-1 in β-cells. GLP-1 inhibited FoxO1 through phosphorylation-dependent nuclear exclusion in pancreatic β (INS832/13) cells. The effect of GLP-1 was suppressed by inhibitors of EGFR (AG1478) and PI 3-kinase (LY294002). In contrast, LY294002 but not AG1478 suppressed insulin-induced FoxO1 phosphorylation. Expression of constitutively nuclear FoxO1 in β-cells prevented the proliferative and antiapoptotic actions of GLP-1 in cultured β-cells and the increase in pancreatic β-cell mass in response to Exendin4 in transgenic mice. Gene expression and chromatin immunoprecipitation assays demonstrated that GLP-1 increases pancreatic and duodenal homeobox gene-1 and Foxa2 expression and inhibits FoxO1 binding to both promoters. We propose that FoxO1 mediates the pleiotropic effects of the glucoincretin hormone on cell proliferation and survival.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“A 1-week daily injection of exendin-4 resulted in a twofold increase in β-cell mass (30).”
From Age-Dependent Decline in β-Cell Proliferation Restricts the Capacity of β-Cell Regeneration in Mice (2009) · cites this paper as [30]
Citations
Cites
(2004) · doi:10.1016/s0092-8674(04)00452-0 · Cited by 1,356 · cited 1×
“Because FoxO1 controls cell cycle progression (27), we examined whether its inhibition is required for GLP1-dependent -cell proliferation.”
BackgroundSelf-citationHohmeier, H. E., Mulder, H., Chen, G., Henkel-Rieger, R., Prentki, M., & Newgard, C. B. (2000) · Diabetes · doi:10.2337/diabetes.49.3.424 · Cited by 917 · cited 1×
“INS832/13 (22) cells (passage 36–70) were grown in RPMI 1640 medium supplemented with 10 mmol/l HEPES, 10% heat-inactivated FCS, 2 mmol/l L-glutamine, 1 mmol/l sodium pyruvate, 50 mol/l -mercaptoethanol, 100 IU/ml penicillin, and 100 g/ml streptomycin at 37°C in a humidified 5% CO2 atmosphere.”
Glucose Toxicity in β-Cells: Type 2 Diabetes, Good Radicals Gone Bad, and the Glutathione Connection
Robertson, R. P., Harmon, J., Tran, P. O., Tanaka, Y., & Takahashi, H. (2003) · Diabetes · doi:10.2337/diabetes.52.3.581 · Cited by 897
Gutniak, M., Ørkov, C., Holst, J. J., Ahrén, B., & Efendić, S. (1992) · New England Journal of Medicine · doi:10.1056/nejm199205143262003 · Cited by 868
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652 · cited 1×
“We next transduced cells with a constitutively nuclear FoxO1 mutant (20) or with control -gal adenovirus.”
MethodSelf-citationNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Self-citationNakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616 · cited 4×
“The mutant transgene carries a single amino acid substitution replacing the main Akt phosphorylation site and is therefore constitutively nuclear (line 305) (19).”
BackgroundMethodSelf-citationHolz IV, G. G., Kiihtreiber, W. M., & Habener, J. F. (1993) · Nature · doi:10.1038/361362a0 · Cited by 594
Glucagon-like Peptide-1 Receptor Signaling Modulates β Cell Apoptosis
Li, Y., Hansotia, T., Yusta, B., Ris, F., Halban, P. A., & Drucker, D. J. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209423200 · Cited by 589
Kitamura, T., Nakae, J., Kitamura, Y., Kido, Y., Biggs, W., Wright, C. V. E., White, M. F., Arden, K. C., & Accili, D. (2002) · Journal of Clinical Investigation · doi:10.1172/jci16857 · Cited by 580 · cited 3×
“We have previously shown that FoxO1 inhibits Pdx1 expression, thereby providing a mechanism by which FoxO1 controls -cell proliferation and insulin secretion (18).”
BackgroundSelf-citationStoffers, D. A., Kieffer, T. J., Hussain, M. A., Drucker, D. J., Bonner-Weir, S., Habener, J. F., & Egan, J. M. (2000) · Diabetes · doi:10.2337/diabetes.49.5.741 · Cited by 576 · cited 2×
“In experimental animal models, GLP-1 increases islet mass (10,11).”
BackgroundFoxO1 protects against pancreatic β cell failure through NeuroD and MafA induction
Kitamura, Y. I., Kitamura, T., Kruse, J.-P., Raum, J. C., Stein, R., Gu, W., & Accili, D. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.08.004 · Cited by 556 · cited 1×
“In cultured -cells, FoxO1 is constitutively phosphorylated and cytoplasmic, probably because of endogenously produced insulin (26).”
BackgroundSelf-citationFrescas, D., Valenti, L., & Accili, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m412357200 · Cited by 533 · cited 4×
“Immunocytochemical analysis of FoxO1 localization in INS832/13 cells after transient transfection with FoxO1-GFP.”
BackgroundMethodSelf-citationFEHMANN, H.-C., GÖKE, R., & GÖKE, B. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-390 · Cited by 528
Pancreatic organogenesis — developmental mechanisms and implications for therapy
Edlund, H. (2002) · Nature Reviews Genetics · doi:10.1038/nrg841 · Cited by 523
Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats
Farilla, L., Hui, H., Bertolotto, C., Kang, E., Bulotta, A., Di Mario, U., & Perfetti, R. (2002) · Endocrinology · doi:10.1210/en.2002-220405 · Cited by 502 · cited 2×
“In experimental animal models, GLP-1 increases islet mass (10,11).”
BackgroundKitamura, T., Nakae, J., Kitamura, Y., et al. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200216857 · Cited by 479
Minireview: The Glucagon-Like Peptides
Drucker, D. J. (2001) · Endocrinology · doi:10.1210/en.142.2.521 · Cited by 421
Buteau, J., Roduit, R., Susini, S., & Prentki, M. (1999) · Diabetologia · doi:10.1007/s001250051238 · Cited by 413 · cited 4×
“It has also been shown that GLP-1 increases Pdx1 expression, but the mechanism is unclear (9).”
BackgroundSelf-citationButeau, J., Foisy, S., Joly, E., & Prentki, M. (2003) · Diabetes · doi:10.2337/diabetes.52.1.124 · Cited by 411 · cited 2×
“In cultured (INS)-cells, GLP-1 acts as a growth factor (9,12,13) via proteolytic maturation of betacellulin (BTC), leading to transactivation of the epidermal growth factor receptor (EGFR), phosphatidylinositol-3 kinase (PI 3-kinase), protein kinase B/Akt, and protein kinase C (9,12,13).”
BackgroundSelf-citationGlucagon-like peptide-1 prevents beta cell glucolipotoxicity
Joly, E., Prentki, M., Buteau, J., El-Assaad, W., Rhodes, C. J., & Rosenberg, L. (2004) · Diabetologia · doi:10.1007/s00125-004-1379-6 · Cited by 337 · cited 2×
“Finally, GLP-1 has recently been shown to prevent -cell apoptosis in animal models of diabetes (11,15) and glucolipotoxicity (16).”
BackgroundSelf-citationFehmann, H. C. (1992) · Endocrinology · doi:10.1210/en.130.1.159 · Cited by 337 · cited 1×
“The biological actions of GLP-1 include stimulation of Insulin expression and insulin biosynthesis (8), presumably via increased expression and activity of the -cell–specific transcription factor pancreatic and duodenal homeobox gene-1 (PDX1) (9,10).”
BackgroundSharma, A., Zangen, D. H., Reitz, P., Taneja, M., Lissauer, M. E., Miller, C. P., Weir, G. C., Habener, J. F., & Bonner-Weir, S. (1999) · Diabetes · doi:10.2337/diabetes.48.3.507 · Cited by 331 · cited 1×
“Thus, Pdx1 haploinsufficient mice fail to increase -cell mass in response to insulin resistance (36), and increased Pdx1 expression is associated with an early burst of -cell proliferation after subtotal pancreatectomy (37).”
BackgroundForkhead transcription factors: new insights into protein kinase B (c-akt) signaling
Kops, G. J. P. L., & Burgering, B. M. T. (1999) · Journal of Molecular Medicine · doi:10.1007/s001099900050 · Cited by 283
Bonner‐Weir, S., & Sharma, A. (2002) · The Journal of Pathology · doi:10.1002/path.1158 · Cited by 282
Kulkarni, R., Jhala, U. S., Winnay, J. N., Krajewski, S., Montminy, M., & Kahn, C. R. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421845 · Cited by 263 · cited 1×
“Thus, Pdx1 haploinsufficient mice fail to increase -cell mass in response to insulin resistance (36), and increased Pdx1 expression is associated with an early burst of -cell proliferation after subtotal pancreatectomy (37).”
BackgroundButeau, J., Foisy, S., Rhodes, C. J., Carpenter, L., Biden, T. J., & Prentki, M. (2001) · Diabetes · doi:10.2337/diabetes.50.10.2237 · Cited by 252 · cited 2×
“In cultured (INS)-cells, GLP-1 acts as a growth factor (9,12,13) via proteolytic maturation of betacellulin (BTC), leading to transactivation of the epidermal growth factor receptor (EGFR), phosphatidylinositol-3 kinase (PI 3-kinase), protein kinase B/Akt, and protein kinase C (9,12,13).”
BackgroundSelf-citationPerspective: Postnatal Pancreatic β Cell Growth
Bonner-Weir, S. (2000) · Endocrinology · doi:10.1210/endo.141.6.7567 · Cited by 247
Protein Kinase B/Akt Prevents Fatty Acid-induced Apoptosis in Pancreatic β-Cells (INS-1)
Wrede, C. E., Dickson, L. M., Lingohr, M. K., Briaud, I., & Rhodes, C. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m208756200 · Cited by 246
Kim, S.-J., Winter, K., Nian, C., Tsuneoka, M., Koda, Y., & McIntosh, C. H. S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500540200 · Cited by 241 · cited 1×
“Moreover, a recent publication demonstrates that FoxO1 mediates the action of glucose-dependent inhibitory peptide on -cell survival by regulating Bax expression (35).”
BackgroundTSUBOI, T., SILVA XAVIER, G. D., HOLZ, G. G., JOUAVILLE, L. S., THOMAS, A. P., & RUTTER, G. A. (2003) · Biochemical Journal · doi:10.1042/bj20021288 · Cited by 216 · cited 1×
“The mechanism by which GLP-1 acts on the mitochondria to preserve the membrane potential remains elusive but may be related to stimulation of mitochondrial ATP synthesis (30).”
BackgroundKang, G., Chepurny, O. G., & Holz, G. G. (2001) · The Journal of Physiology · doi:10.1111/j.1469-7793.2001.0375c.xd · Cited by 204
Therapy of type 2 diabetes mellitus based on the actions of glucagon‐like peptide‐1
Holst, J. J. (2002) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.328 · Cited by 155
Transgenic rescue of insulin receptor–deficient mice
Okamoto, H., Nakae, J., Kitamura, T., Park, B.-C., Dragatsis, I., & Accili, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421645 · Cited by 151 · cited 1×
“RNA was isolated using Qiagen kits (Valencia, CA), and quantitative real-time PCR was performed as described previously (25).”
MethodSelf-citationGlucagon-Like Peptide-I and the Control of Insulin Secretion in the Normal State and in NIDDM
Thorens, B., & Waeber, G. (1993) · Diabetes · doi:10.2337/diab.42.9.1219 · Cited by 119
MacDonald, P. E., Wang, X., Xia, F., El-kholy, W., Targonsky, E. D., Tsushima, R. G., & Wheeler, M. B. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m307612200 · Cited by 117
Nakae, J., Kitamura, T., Ogawa, W., Kasuga, M., & Accili, D. (2001) · Biochemistry · doi:10.1021/bi015532m · Cited by 78
Self-citationHolz, G. G., & Chepurny, O. G. (2005) · Science's STKE · doi:10.1126/stke.2682005pe2 · Cited by 45
Glucagon-like peptide-I and the control of insulin secretion in the normal state and in NIDDM
Thorens, B., & Waeber, G. (1993) · Diabetes · doi:10.2337/diabetes.42.9.1219 · Cited by 33
Sato, A., Wang, P.-C., & Ohgawara, H. (2002) · Pancreas · doi:10.1097/00006676-200207000-00019 · Cited by 12 · cited 1×
“GLP-1 induced a rise in cAMP levels in -Gal–transduced cells, as did treatment with 10 mmol/l nicotinamide (29).”
BackgroundDawson, L. Y. (1993) · Diabetes · doi:10.2337/diab.42.8.1219 · Cited by 7
Cited by
Biology of Incretins: GLP-1 and GIP
Baggio, L. L., & Drucker, D. J. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.054 · Cited by 3,639
The role of incretins in glucose homeostasis and diabetes treatment
Kim, W., & Egan, J. M. (2008) · Pharmacological Reviews · doi:10.1124/pr.108.000604 · Cited by 824
“…localization of PDX-1 involves the phosphorylation of FoxO1 via transactivation of the EGFR and PI-3K/PKB pathway, resulting in deactivation and nuclear exclusion of FoxO1 and consequent disinhibition of Foxa2dependent pdx-1 gene promoter activity (Kitamura et al., 2002; Buteau et al., 2006).”
BackgroundMechanisms of action of glucagon-like peptide 1 in the pancreas
Doyle, M. E., & Egan, J. M. (2007) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2006.11.007 · Cited by 680
The role of gut hormones in glucose homeostasis
Drucker, D. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30076 · Cited by 614
The role of FoxO in the regulation of metabolism
Gross, D. N., van den Heuvel, A. P. J., & Birnbaum, M. J. (2008) · Oncogene · doi:10.1038/onc.2008.25 · Cited by 540
“Most notably, transgenic rescue of Pdx-1 expression in the beta cell alone is able to restore beta cell mass and function in the diabetic IRS-2 knockout mouse (Kushner et al., 2002).”
BackgroundInfluential
Metadata
- Authors
- Buteau, J., Spatz, M. L., & Accili, D.
- Affiliations
- Columbia University Irving Medical Center (US)
- Venue
- Diabetes
- Publisher
- American Diabetes Association
- Published
- 2006-05-01
- Volume
- 55
- Issue
- 5
- Pages
- 1190-1196
- ISSN
- 0012-1797 (ISSN-L)
- 1939-327X
- OpenAlex
- W2122464768
- Cited by
- 178
- References
- 38
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 2 · 2023: 6 · 2022: 5 · 2021: 2 · 2020: 5 · 2019: 3 · 2018: 6 · 2017: 7 · 2016: 12 · 2015: 11 · 2014: 13 · 2013: 10 · 2012: 15
- FWCI
- 16.61
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Diabetes (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-64819, R01DK064819)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- FOXO1, glucagon-like peptide-1, beta-cell mass, beta-cell proliferation, beta-cell apoptosis, nuclear exclusion, EGFR signaling, PI3K/Akt signaling, exendin-4, PDX1, FOXA2, transcriptional regulation, insulin
- MeSH terms
- Forkhead Box Protein O1, Animals, Cell Division, Cell Line, Cell Survival, Glucagon-Like Peptides, Glucagon, Glucose, Insulin, Islets of Langerhans, Mice, Transgenic, Peptide Fragments, Green Fluorescent Proteins, Mice, Forkhead Transcription Factors, Glucagon-Like Peptide 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.